Healthcare Realty Trust Inc (HR) concluded trading on Wednesday at a closing price of $15.09, with 3.48 million shares of worth about $52.51 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.06% during that period and on Wednesday the price saw a loss of about -0.85%. Currently the company’s common shares owned by public are about 380.59M shares, out of which, 377.05M shares are available for trading.
Stock saw a price change of -3.33% in past 5 days and over the past one month there was a price change of -13.43%. Year-to-date (YTD), HR shares are showing a performance of -12.42% which decreased to -27.42% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $13.86 but also hit the highest price of $21.15 during that period. The average intraday trading volume for Healthcare Realty Trust Inc shares is 3.33 million. The stock is currently trading -6.84% below its 20-day simple moving average (SMA20), while that difference is down -8.91% for SMA50 and it goes to -11.83% lower than SMA200.
Healthcare Realty Trust Inc (NYSE: HR) currently have 380.59M outstanding shares and institutions hold larger chunk of about 104.37% of that.
The stock has a current market capitalization of $5.75B and its 3Y-monthly beta is at 0.80. It has posted earnings per share of -$0.73 in the same period. It has a debt-to-equity ratio of 0.80. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HR, volatility over the week remained 2.25% while standing at 2.69% over the month.
Analysts are in expectations that Healthcare Realty Trust Inc (HR) stock would likely to be making an EPS of -$0.11 in the current quarter, while forecast for next quarter EPS is -$0.12 and it is -$0.41 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.13 which is -$0.08 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.09 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -776.75% while it is estimated to increase by 43.45% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Deutsche Bank on January 30, 2024 offering a Hold rating for the stock and assigned a target price of $18 to it.
